Alpha 2.0
Login Register
» Articles » PMID: 16926262

GnRH Agonist for Luteal Support in IVF? Setting the Balance Between Enthusiasm and Caution

Overview
Journal Hum Reprod
Publisher Oxford University Press
Specialty Reproductive Medicine
Date 2006 Aug 24
PMID 16926262
Citations 5
Authors
Cornelis B Lambalk
Roy Homburg
Affiliations
Soon will be listed here.
Citing Articles

Single-dose administration of a short-acting gonadotropin-releasing hormone agonist does not affect cycle outcome in frozen-thawed embryo transfer cycles.

Wang H, Tang X, Bukulmez O, Deng C, Yu Q, Zhou Y J Int Med Res. 2021; 49(5):3000605211012247.

PMID: 33947255 PMC: 8113920. DOI: 10.1177/03000605211012247.

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.

Fusi F, Brigante C, Zanga L, Mignini Renzini M, Bosisio C, Fadini R Reprod Biol Endocrinol. 2019; 17(1):103.

PMID: 31783862 PMC: 6884808. DOI: 10.1186/s12958-019-0543-2.

Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Pirard C, Loumaye E, Laurent P, Wyns C Int J Endocrinol. 2015; 2015:727569.

PMID: 25945092 PMC: 4402188. DOI: 10.1155/2015/727569.

Assessment of the luteal phase in stimulated and substituted cycles.

Fatemi H Facts Views Vis Obgyn. 2014; 1(1):30-46.

PMID: 25478069 PMC: 4251280.

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome.

Inamdar D, Majumdar A J Hum Reprod Sci. 2013; 5(3):279-84.

PMID: 23532169 PMC: 3604836. DOI: 10.4103/0974-1208.106341.